Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.31
+0.11 (2.12%)
At close: Mar 6, 2026, 4:00 PM EST
5.29
-0.02 (-0.38%)
After-hours: Mar 6, 2026, 4:10 PM EST
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 71 employees as of December 31, 2024. The number of employees decreased by 29 or -29.00% compared to the previous year.
Employees
71
Change (1Y)
-29
Growth (1Y)
-29.00%
Revenue / Employee
$434,211
Profits / Employee
-$366,394
Market Cap
84.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Seres Therapeutics | 103 |
| PolyPid | 73 |
| aTyr Pharma | 65 |
| PMV Pharmaceuticals | 47 |
| Pyxis Oncology | 44 |
| Vivani Medical | 37 |
VRCA News
- 2 days ago - Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026 - GlobeNewsWire
- 12 days ago - Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 23 days ago - Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer - GlobeNewsWire
- 26 days ago - Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts - GlobeNewsWire
- 3 months ago - Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway - GlobeNewsWire
- 3 months ago - Verrica Pharmaceuticals Inc. (VRCA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewsWire